US · guidance

CMS Pub. 100-18, ch. 6, § 30.1.4

Meeting Administration

activein force · 2026-09-17 – presentas-observed

The Part D sponsor’s P&T committee should meet on a regular basis, but no less than quarterly.

P&T committee decisions regarding formulary development or revision must be documented in

writing.

History

(Rev. 2, Issued: 07-18-08; Effective/Implementation Date: 07-18-08)

Provenance

Source: cms.gov
Retrieved: 2026-09-17
Edition: iom-2026-09-17
Content hash: 86465ec40d66bb317b4030b83c370c93c9f08b85dca7eb391a797ada047a27b5

View the official source →

The link goes to the issuing authority’s own document — the one we read to produce this record. Where a source publishes whole titles rather than sections, your browser may need a moment to jump to the provision.

Unofficial copy of government-published law, reproduced from official sources with full provenance. Not an official publication; verify against official sources before relying on it in a filing. Records in the 'guidance' corpus, and only that corpus, are sub-regulatory (interpretive guidelines, survey procedures) and are not binding law. Validity bounds follow each jurisdiction's declared temporalBasis.

Coverage · API docs